Scooping Mobilization With and Without Scapulothoracic Mobilization in Patients of Lateral Epicondylalgia
NCT ID: NCT06869733
Last Updated: 2025-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2023-05-02
2024-07-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Scapular PNF Versus Shoulder Strengthening Exercises in Patients With Lateral Epicondylitis.
NCT05947968
Mobilition With Movement and Soft Tissue Mobiiztion in Tennis Elbow
NCT05039827
ADDITIONAL EFFECTS OF MOBILIZATION WITH MOVEMENT WITH UPPER QUADRANT CORE STRENGTHENING IN ROTATOR CUFF RELATED PAIN:A RANDOMIZED CONTROLLED TRAIL
NCT06723730
Effectiveness of Scapular Muscle Training in Improving Grip Strength Among Lateral Epicondylitis Patients
NCT06438328
Influence of Proximal Motor Control in Treating Lateral Epicondylitis
NCT05447468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scooping Mobilization
Group A treated with scooping mobilization only.
Scooping Mobilization
Group A treated with only scooping mobilization with frequency of 2 to 3 times in a week for consecutive 4 weeks.
Scooping Mobilization with Scapulothoracic mobilization
Group B treated with scooping mobilization with scapulothoracic mobilization.
Scooping Mobilization with Scapulothoracic mobilization
Group B treated with scooping mobilization with scapulothoracic mobilization, which was given 2 to 3 times in a week for consecutive 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scooping Mobilization
Group A treated with only scooping mobilization with frequency of 2 to 3 times in a week for consecutive 4 weeks.
Scooping Mobilization with Scapulothoracic mobilization
Group B treated with scooping mobilization with scapulothoracic mobilization, which was given 2 to 3 times in a week for consecutive 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pain and tenderness around lateral epicondyle
* Pain on resisted elbow extension ,wrist extension and gripping activities
* Gender both male and female.
* Scapular Dyskinesia.
* Positive Cozen test and maudsley test for lateral epicondylalgia.
* With moderate pain intensity on Numeric Pain Rating Scale (NPRS) with a score of 3 or higher
Exclusion Criteria
* Cervical radiculopathy.
* Local steroid injection
* History of fracture of humerus, radius, ulna which is affected upper extremity
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Humera Mubashar, MSOMPT
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Humera Mubashar
Lahore, Punjab Province, Pakistan
Dr. Faiza Amjad
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/RCR&AHS/24/0125
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.